secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001104659-23-098668
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hepion CMO Todd Hobbs resigns; Stephen Harrison appointed Consultant Medical Director
--------------------------------------------------------------------------------

- Dr. Todd Hobbs resigned as CMO effective September 29, 2023; resignation not due to any disagreement with the Company.
- Company appointed Dr. Stephen Harrison as Consultant Medical Director; he chairs the Scientific Advisory Board.
- Dr. Harrison previously served as Consultant Medical Director from Oct 2019 to Feb 2021; leads Pinnacle Clinical Research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923098668/0001104659-23-098668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465923098668/tm2325511d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-098668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer